Resistance to prostate-cancer treatment is driven by immune cells

Authors :: Matthew D. Galsky
Source :: Nature. 559:338-339
Publication Year :: 2018
Publisher :: Springer Science and Business Media LLC, 2018.
Abstract: Prostate-cancer treatment usually fails after time as resistance to therapy develops. It emerges from studies of mice and human cells that a population of immune cells can cause this type of treatment resistance. Prostate-cancer treatment usually fails after time as resistance to therapy develops. It emerges from studies of mice and human cells that a population of immune cells can cause this type of treatment resistance.